ITGAM and cancer: The results show that both the volume (Figure 5E) and weight (Figure 5F) of tumors from STAT6−/− CD11b+ cells are less than those from STAT6+/+ CD11b+ cells, suggesting that CD11b+ cells derived from STAT6−/− mice are associated with the reduction of cancer development.